Related Experiment Video
Updated: Nov 11, 2025
10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
14.8K
Novel treatments for alcoholic hepatitis
Margarita N German1, Jessica Musto, Michael R Lucey
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Current Opinion in Gastroenterology
|March 26, 2021
Summary
New treatments for alcohol-associated liver disease (ALD) are emerging, focusing on alcohol use disorder (AUD) integration and liver transplantation. Promising therapies target the gut-liver axis and inflammation, with abstinence remaining crucial for managing alcoholic hepatitis.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Therapeutics
Background:
- Alcohol-associated liver disease (ALD) is a leading cause of liver transplantation.
- Alcohol use disorder (AUD) treatment integration is vital for ALD management.
- Limited therapeutic options exist for alcoholic hepatitis.
Purpose of the Study:
- Review recent literature on ALD therapeutics.
- Discuss integrating AUD treatment into ALD care.
- Evaluate liver transplantation for alcoholic hepatitis.
Main Methods:
- Literature review of the latest research.
- Analysis of therapeutic targets for alcoholic hepatitis.
- Assessment of liver transplantation outcomes in ALD.
Main Results:
- Emerging therapies target the gut-liver axis, inflammation, and hepatic regeneration.
- Fecal transplantation shows favorable 1-year outcomes.
- n-Acetylcysteine, corticosteroids, G-CSF, and IL-22 improve short-term outcomes.
- Liver transplantation is a life-saving option for ALD with excellent survival rates.
Conclusions:
- Promising therapeutic options are under clinical investigation for ALD.
- Alcohol abstinence is paramount for managing alcoholic hepatitis.
- Liver transplantation remains a critical treatment for end-stage ALD.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
650
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
650
01:29Chronic Pancreatitis II: Collaborative Care
168
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
168
01:26Diseases of the Liver and Gallbladder
1.6K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
01:22Alzheimer's Disease: Treatment
539
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
539
01:29Drugs for Treatment of Ulcerative Colitis in IBD
295
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
295
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
55
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
55